The next steps in managing this case -staging the cancer, discussing treatment options with the patient, and potentially considering genetic counseling.
Treatment options - surgery, chemotherapy, radiation therapy, and hormone therapy.
The prognosis is generally good for ER+/PR+ HER2- invasive ductal carcinoma, especially when caught early, and follow-up counseling should address recurrence risk and the importance of regular checkups.
Next step: Staging with imaging (mammogram, ultrasound, MRI).
Treatment: Surgery (lumpectomy/mastectomy), hormone therapy, possibly chemotherapy/radiation.
Prognosis: Generally good with ER+/PR+; regular follow-up essential for recurrence monitoring.
For this patient, the next step is usually surgery to remove the lump and check nearby lymph nodes. Because her tumor is hormone receptor-positive, she’ll likely benefit from hormone therapy after surgery to help keep the cancer from coming back. Radiation and possibly chemotherapy might also be needed depending on the surgery results. With the right treatment, her outlook can be good, but regular follow-ups are important to catch any changes early and support her through recovery.